Farmaci per l'autoimmunità

Queste aziende sviluppano farmaci che calmano il sistema immunitario in malattie come lupus e artrite reumatoide.
+16,4%
in 3 mesi · S&P 500 −2,1%

Indicatori chiave

Salute
50 / 100
Fragile
Solido
Prezzo
P/E 25
Economico
Caro
In rialzo su 1 anno
30 su 46
Wallet su 90 giorni
1 / 2 acquisti / vendite
Acquisti
Vendite
Salute e prezzo: rispetto agli altri tag.

Le 52 aziende

LLY
+22,0%
JNJ
+9,4%
ABBV
+17,9%
Dimensione: peso nel tag. Colore: variazione nel periodo.
Vedi tutte le aziende
L
Eli Lilly
LLY
51,6%
+22,0%
J
Johnson & Johnson
JNJ
25,5%
+9,4%
A
AbbVie
ABBV
20,0%
+17,9%
K
Kymera Therapeutics
KYMR
0,4%
+5,1%
S
Spyre Therapeutics
SYRE
0,4%
−0,6%
T
TG Therapeutics
TGTX
0,4%
+30,9%
I
Immunovant
IMVT
0,3%
−21,8%
O
Oruka Therapeutics
ORKA
0,3%
−6,5%
D
Dianthus Therapeutics
DNTH
0,2%
−20,1%
V
Viridian Therapeutics
VRDN
0,1%
+33,7%
X
Xencor
XNCR
0,1%
+60,4%
C
Celldex Therapeutics
CLDX
<0,1%
−31,2%
T
First Tracks Biotherapeutics
TRAX
<0,1%
+8,0%
Z
Zenas BioPharma
ZBIO
<0,1%
−8,2%
N
Nektar Therapeutics
NKTR
<0,1%
−48,7%
V
Vor Biopharma
VOR
<0,1%
−15,6%
J
Jade Biosciences
JBIO
<0,1%
−31,2%
O
Odyssey Therapeutics
ODTX
<0,1%
−8,2%
C
Corvus Pharmaceuticals
CRVS
<0,1%
−28,6%
G
Monte Rosa Therapeutics
GLUE
<0,1%
−39,1%
A
Alumis
ALMS
<0,1%
−78,0%
C
Cullinan Therapeutics
CGEM
<0,1%
−50,1%
A
Attovia Therapeutics
ATTO
<0,1%
−33,4%
C
Climb Bio
CLYM
<0,1%
−40,6%
A
Aclaris Therapeutics
ACRS
<0,1%
−33,8%
S
Shattuck Labs
STTK
<0,1%
−37,1%
A
Avalo Therapeutics
AVTX
<0,1%
−61,1%
C
Cabaletta Bio
CABA
<0,1%
−55,7%
E
Enanta Pharmaceuticals
ENTA
<0,1%
−14,3%
K
Kyverna Therapeutics
KYTX
<0,1%
−43,6%
E
Evommune
EVMN
<0,1%
−46,5%
Q
Q32 Bio
QTTB
<0,1%
−45,4%
A
Artiva Biotherapeutics
ARTV
<0,1%
−65,8%
P
Palisade Bio
PALI
<0,1%
−47,9%
Y
Yarrow Bioscience
YARW
<0,1%
−56,4%
F
Fate Therapeutics
FATE
<0,1%
−51,1%
Z
Zura Bio
ZURA
<0,1%
−78,2%
C
Cue Biopharma
CUE
<0,1%
−41,7%
A
Adicet Bio
ACET
<0,1%
−68,2%
A
Abivax
ABVX
−27,5%
A
argenx
ARGX
−2,8%
A
Aurinia Pharmaceuticals
AUPH
+2,9%
A
Autolus Therapeutics
AUTL
−48,7%
B
Bambusa Therapeutics
BBTX
E
Electra Therapeutics
ETRA
L
Lakefront Biotherapeutics
LKFT
+23,5%
L
Lycia Therapeutics
LYCA
M
Mesoblast
MESO
−22,0%
M
MoonLake Immunotherapeutics
MLTX
−23,5%
N
Novartis
NVS
+5,6%
R
Roche Holdings
RHHBY
0,0%
R
Roivant Sciences
ROIV
+9,1%